Superior mesenteric artery blood flow and indomethacin-induced intestinal injury and inflammation

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 271, Issue 4 34-4, 1996, Pages

  Battarbee, Harold D ^a   Grisham, Matthew B ^a   Johnson, Glenda G ^a   Zavecz, James H ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

enteropathy; ileum; ischemia; jejunum; myeloperoxidase; nonsteroidal antiinflammatory drug

Indexed keywords

INDOMETACIN; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD FLOW VELOCITY; DRUG EFFECT; INTESTINE BLOOD FLOW; INTESTINE INJURY; INTESTINE ISCHEMIA; INTESTINE MUCOSA PERMEABILITY; INTESTINE ULCER; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SUPERIOR MESENTERIC ARTERY; SYSTEMIC VASCULAR RESISTANCE;

EID: 0029861979     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1996.271.4.g605     Document Type: Article

References (43)

1. Anthony, A., A. P. Dhillon, G. Nygård, M. Hudson, C. Piasecki, P. Strong, M. A. Trevethick, N. M. Clayton, C. C. Jordon, R. E. Pounder, and A. J. Wakefield. Early histological features of small intestinal injury induced by indomethacin. Aliment Pharmacol. Ther. 7: 29-40, 1993.
2. Arndt, H., H. D. Palitzsch, M. B. Grisham, and D. N. Granger. Metronidazole inhibits leukocyte-endothelial cell adhesion in rat mesenteric venules. Gastroenterology 106: 1271-1276, 1994.
3. Banerjee, A. K., and T. J. Peters. Experimental non-steroidal anti-inflammatory drug-induced enteropathy in the rat: similarities to inflammatory bowel disease and effect of thromboxane synthetase inhibitors. Gut 31: 1358-1364, 1990.
4. Beck, W. S., H. T. Schneider, K. Dietzel, B. Nuernberg, and K. Brune. Gastrointestinal ulcerations induced by anti-inflammatory drugs in rats. Arch. Toxicol. 64: 210-217, 1990.
5. Benoit, J. N., W. A. Womack, R. J. Korthuis, W. H. Wilborn, and D. N. Granger. Chronic portal hypertension: effects on gastrointestinal blood flow distribution. Am. J. Physiol. 250 (Gastrointest. Liver Physiol. 13): G535-G539, 1986.
6. Bjarnason, I., B. Fehilly, P. Smethurst, I. S. Menzies, and A. J. Levi. Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man. Gut 32: 275-277, 1991.
7. Bjarnason, I., J. Hayllar, A. J. MacPherson, and A. S. Russell. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 104: 1832-1847, 1993.
8. Bjarnason, I., and A. MacPherson. The changing gastrointestinal side effect profile of non-steroidal anti-inflammatory drugs. A new approach for the prevention of a new problem. Scand. J. Gastroenterol. 24, Suppl. 163: 56-64, 1989.
9. Bjarnason, I., P. Smethurst, C. G. Fenn, C. E. Lee, I. S. Menzies, and A. J. Levi. Misoprostal reduces indomethacin-induced changes in human small intestinal permeability. Dig. Dis. Sci. 34: 407-411, 1989.
10. 51Cr-EDTA in rats with experimentally induced enteropathy. Gut 26: 579-585, 1985.
11. Bjarnason, I., G. Zanelli, T. Smith, P. Prouse, P. Williams, P. Smethurst, G. Delacy, M. J. Gumpel, and A. H. Levi. Non-steroidal anti-inflammatory drug-induced intestinal inflammation in humans. Gastroenterology 93: 480-489, 1987
12. Brodie, D. A., P. G. Cook, B. J. Bauer, and G. E. Dagle. Indomethacin-induced intestinal lesions in the rat. Toxicol. Appl. Pharmacol. 17: 615-624, 1970.
13. Broughton-Smith, N. K., J. L. Wallace, G. P. Morris, and B. J. R. Whittle. Evaluation of the role of arachidonic acid metabolites in a rat model of Crohn's disease (Abstract). Gastroenterology 88: A1332, 1985.
14. Chmaisse, H. M., J. S. Antoon, P. R. Kvietys, M. B. Grisham, and M. A. Perry. Role of leukocytes in indomethacin-induced small bowel injury in the rat. Am. J. Physiol. 266 (Gastrointest. Liver Physiol. 29): G239-G246, 1994.
15. Crissinger, K. D., P. R. Kvietys, and D. N. Granger. Pathophysiology of gastrointestinal mucosal permeability. J. Intern. Med. 228, Suppl. 1: 145-154, 1990.
16. Fang, W., A. Broughton, and E. D. Jacobson. Indomethacin-induced intestinal inflammation. Dig. Dis. Sci. 22: 749-760, 1977.
17. Fries, J. F., S. R. Miller, B. W. Spitz, C. A. Williams, H. B. Hubert, and D. A. Bloch. Toward an epidemiology of gastropathy associated with nonsteroidal anti-inflammatory drug use. Gastroenterology 96: 647-655, 1989.
18. Granger, D. N., J. N. Benoit, M. Suzuki, and M. B. Grisham. Leukocyte adherence to venular endothelium during ischemia-reperfusion injury. Am. J. Physiol. 257 (Gastrointest. Liver Physiol. 20): G683-G688, 1989.
19. Grisham, M. B., J. N. Benoit, and D. N. Granger. Assessment of leukocyte involvement during ischemia and reperfusion of intestine. Methods Enzymol. 186: 729-741, 1990.
20. Grisham, M. B., and D. N. Granger. Neutrophil-mediated mucosal injury. Role of reactive metabolites. Dig. Dis. Sci. 33: 6S-15S, 1988.
21. Grisham, M. B., L. A. Hernandez, and D. N. Granger. Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am. J. Physiol. 251 (Gastrointest. Liver Physiol. 14): G567-G574, 1986.
22. Haywood, J. R., R. A. Shaffer, C. Fastinow, G. D. Fing, and M. J. Brody. Regional blood flow measurements with pulsed Doppler flowmeter in conscious rat. Am. J. Physiol. 241 (Heart Circ. Physiol. 10): H273-H278, 1981.
23. Kent, T. H., R. M. Cardelli, and F. W. Stamler. Small intestinal ulcers and intestinal flora in rats given indomethacin. Am. J. Pathol. 54: 237-245, 1969.
24. Kitahora, T., and P. T. Guth. Effect of aspirin plus hydrochloric acid on the gastric mucosal microcirculation. Gastroenterology 93: 810-817, 1987.
25. Kvietys, P. R., B. Twohig, J. Dazell, and R. D. Specian. Ethanol-induced injury to the gastric mucosa: role of xanthine oxidase-derived radicals. Gastroenterology 98: 909-920, 1990.
26. Main, I. H. M., and B. J. R. Whittle. Effects of indomethacin on rat gastric acid secretion and mucosal blood flow. Br. J. Pharmacol. 47: 666P, 1973.
27. Miura, S., M. Suematsu, S. Tanaka, H. Nagata, S. Houzawa, M. Suzuki, I. Kurose, H. Serizawa, and M. Tsuchiya. Microcirculatory disturbance in indomethacin-induced intestinal ulcer. Am. J. Physiol. 261 (Gastrointest. Liver Physiol. 24): G213-G219, 1991.
28. Nygård, G., A. Anthony, C. Piasecki, M. A. Trevethick, M. Hudson, A. P. Dhillon, R. E. Pounder, and A. J. Wakefield. Acute indomethacin-induced jejunal injury in the rat: early morphological and biochemical changes. Gastroenterology 106: 567-575, 1994.
29. Robert, A. An intestinal disease produced experimentally by prostaglandin deficiency. Gastroenterology 69: 1045-1047, 1975.
30. Robert, A., and T. Asano. Resistance of germ free rats to indomethacin-induced intestinal lesions. Prostaglandins 14: 333-341, 1977.
31. Sartor, R. B. Animal models of intestinal inflammation: relevance to inflammatory bowel disease. In: Inflammatory Bowel Disease, edited by R. P. MacDermott and W. P. Stenson. New York: Elsevier, 1991, p. 337-353.
32. Satoh, H., P. H. Guth, and M. I. Grossman. Role of food in gastrointestinal ulceration produced by indomethacin in the rat. Gastroenterology 83: 210-215, 1982.
33. Satoh, H., P. L. Guth, and M. I. Grossman. Role of bacteria in gastric ulceration produced by indomethacin in the rat: cytoprotective action of antibiotics. Gastroenterology 84: 483-489, 1983.
34. Shehadeh, Z., W. P. Price, and E. D. Jacobson. Effects of vasoactive agents on intestinal blood flow and motility in the dog. Am. J. Physiol. 216: 386-392, 1969.
35. Somasundaram, S., A. J. MacPherson, J. Hayllar, P. Saratchandra, and I. Bjarnason. Enterocyte mitochondrial damage due to NSAID in the rat. Gut 33, Suppl.: S5, 1992.
36. Vilaseca, J., A. Salas, F. Guarner, R. Rodrigues, M. Martinez, and J. Malagelada. Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis. Gut 31: 539-544, 1990.
37. Wakefield, A. J., A. M. Sawyer, A. P. Dhillon, R. M. Pittilo, P. M. Rowles, A. A. M. Lewis, and R. E. Pounder. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 2: 1057-1062, 1989
38. Wallace, J. L. Lipid mediators of inflammation in gastric ulcer. Am. J. Physiol. 258 (Gastrointest. Liver Physiol. 21): G1-G11, 1990.
39. Wallace, J. L., K. E. Arfors, and G. Webb-McKnight. A monoclonal antibody against the CD18 leukocyte adhesion molecule prevents indomethacin-induced gastric damage in the rabbit. Gastroenterology 100: 878-883, 1991.
40. Wallace, J. L., C. M. Keenan, and D. N. Granger. Gastric ulceration induced by non-steroidal anti-inflammatory drugs is a neutrophil-dependent process. Am. J. Physiol. 259 (Gastrointest. Liver Physiol. 22): G462-G467, 1990.
41. Whittle, B. J. R. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 80: 94-98, 1981.
42. Whittle, B. J. R. Arachidonic acid metabolism and the gastrointestinal toxicity of anti-inflammatory agents. Prostaglandins 21, Suppl.: 113-118, 1981.
43. Yamada, T., E. Deitch, R. D. Specian, M. A. Perry, R. B. Sartor, and M. B. Grisham. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation 17: 641-661, 1993.